1. All-cause and cardiovascular mortality associated with sulphonylurea and metformin therapy in type 2 diabetes. (3rd April 2018) Authors: Ioacara, Sorin; Guja, Cristian; Reghina, Aura; Martin, Sorina; Sirbu, Anca; Fica, Simona Journal: Endocrine research Issue: Volume 43:Number 2(2018) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Assessment of Romanian Type 2 Diabetes patients treated with insulin glargine after failure of non-insulin therapy in daily clinical practice. (October 2016) Authors: Guja, Cristian; Botnariu, Gina; Cerghizan, Anca; Dinca, Mihaela; Popa, Amorin; Suciu, Gina Journal: Diabetes research and clinical practice Issue: Volume 120(2016)Supplement 1 Page Start: S101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Associations of smoking with cardiometabolic profile and renal function in a Romanian population-based sample from the PREDATORR cross-sectional study. (2nd October 2017) Authors: Popa, Simona Georgiana; Moţa, Maria; Mihălţan, Florin Dumitru; Popa, Adina; Munteanu, Ioana; Moţa, Eugen; Serafinceanu, Cristian; Guja, Cristian; Hâncu, Nicolae; Catrinoiu, Doina; Lichiardopol, Radu; Bala, Cornelia; Mihai, Bogdan; Radulian, Gabriela; Roman, Gabriela; Timar, Romulus Journal: European journal of general practice Issue: Volume 23:Number 1(2017:Mar.) Page Start: 165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Cardiovascular Mortality in Type 2 Diabetes Patients with Incident Exposure to Insulin Glargine. (14th June 2015) Authors: Ioacara, Sorin; Guja, Cristian; Reghina, Aura; Martin, Sorina; Sirbu, Anca; Fica, Simona Other Names: Strain David Academic Editor. Journal: Journal of diabetes research Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial. Issue 3 (11th November 2018) Authors: Bain, Stephen C.; Mosenzon, Ofri; Arechavaleta, Rosario; Bogdański, Pawel; Comlekci, Abdurrahman; Consoli, Agostino; Deerochanawong, Chaicharn; Dungan, Kathleen; Faingold, Maria C.; Farkouh, Michael E.; Franco, Denise R.; Gram, Jeppe; Guja, Cristian; Joshi, Pankaj; Malek, Rachid; Merino‐Torres, J... Journal: Diabetes, obesity & metabolism Issue: Volume 21:Issue 3(2019) Page Start: 499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CARMELINA: An important piece of the DPP-4 inhibitor CVOT puzzle. (July 2019) Authors: Schernthaner, Guntram; Wanner, Christoph; Jurišić-Eržen, Dubravka; Guja, Cristian; Gumprecht, Janusz; Jarek-Martynowa, Iwona R.; Karasik, Avraham; Lalić, Nebojša; Mankovsky, Boris N.; Prázný, Martin; Tankova, Tsvetalina; Tsur, Anat; Wascher, Thomas C; Wittmann, István Journal: Diabetes research and clinical practice Issue: Volume 153(2019) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of exenatide QW or placebo, both added to titrated insulin glargine, in uncontrolled type 2 diabetes: The DURATION‐7 randomized study. Issue 7 (25th March 2018) Authors: Guja, Cristian; Frías, Juan P.; Somogyi, Aniko; Jabbour, Serge; Wang, Hui; Hardy, Elise; Rosenstock, Julio Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 7(2018) Page Start: 1602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION‐8 randomized controlled trial. Issue 6 (19th April 2018) Authors: Frías, Juan P.; Hardy, Elise; Ahmed, Azazuddin; Öhman, Peter; Jabbour, Serge; Wang, Hui; Guja, Cristian Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 6(2018) Page Start: 1520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study. Issue 6 (4th February 2018) Authors: Jabbour, Serge A.; Frías, Juan P.; Guja, Cristian; Hardy, Elise; Ahmed, Azazuddin; Öhman, Peter Journal: Diabetes, obesity & metabolism Issue: Volume 20:Issue 6(2018) Page Start: 1515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Exenatide and dapagliflozin combination improves markers of liver steatosis and fibrosis in patients with type 2 diabetes. Issue 3 (14th December 2019) Authors: Gastaldelli, Amalia; Repetto, Enrico; Guja, Cristian; Hardy, Elise; Han, Jenny; Jabbour, Serge A.; Ferrannini, Ele Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 3(2020) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗